May 25, 2017
BioLineRx Reports First Quarter 2017 Financial Results
May 22, 2017
BioLineRx Announces Regulatory Submission for Phase 1b Trial of BL-8040 in Combination with Atezolizumab in AML
May 16, 2017
BioLineRx to Report First Quarter 2017 Results on May 25, 2017
May 3, 2017
BioLineRx to Initiate Phase 3 Study with BL-8040 as Novel Stem Cell Mobilization Treatment Following Successful Meeting with FDA